UK 447841Alternative Names: UK-447,841
Latest Information Update: 11 Feb 2014
At a glance
- Originator Pfizer
- Mechanism of Action Neprilysin inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Female sexual dysfunction
Most Recent Events
- 01 Jan 2008 Discontinued - Phase-II for Female sexual dysfunction in Sweden (PO)
- 02 Aug 2004 Phase-II clinical trials in Female sexual dysfunction in Sweden (PO)